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Abstract
Mesenchymal stem cells (MSCs) show unexplained differences in differentiation potential. In this study, differentiation of
human (h) MSCs derived from embryonic, fetal and adult sources toward cardiomyocytes, endothelial and smooth muscle
cells was investigated. Labeled hMSCs derived from embryonic stem cells (hESC-MSCs), fetal umbilical cord, bone marrow,
amniotic membrane and adult bone marrow and adipose tissue were co-cultured with neonatal rat cardiomyocytes
(nrCMCs) or cardiac fibroblasts (nrCFBs) for 10 days, and also cultured under angiogenic conditions. Cardiomyogenesis was
assessed by human-specific immunocytological analysis, whole-cell current-clamp recordings, human-specific qRT-PCR and
optical mapping. After co-culture with nrCMCs, significantly more hESC-MSCs than fetal hMSCs stained positive for a-actinin,
whereas adult hMSCs stained negative. Furthermore, functional cardiomyogenic differentiation, based on action potential
recordings, was shown to occur, but not in adult hMSCs. Of all sources, hESC-MSCs expressed most cardiac-specific genes.
hESC-MSCs and fetal hMSCs contained significantly higher basal levels of connexin43 than adult hMSCs and co-culture with
nrCMCs increased expression. After co-culture with nrCFBs, hESC-MSCs and fetal hMSCs did not express a-actinin and
connexin43 expression was decreased. Conduction velocity (CV) in co-cultures of nrCMCs and hESC-MSCs was significantly
higher than in co-cultures with fetal or adult hMSCs. In angiogenesis bioassays, only hESC-MSCs and fetal hMSCs were able
to form capillary-like structures, which stained for smooth muscle and endothelial cell markers.Human embryonic and fetal
MSCs differentiate toward three different cardiac lineages, in contrast to adult MSCs. Cardiomyogenesis is determined by
stimuli from the cellular microenvironment, where connexin43 may play an important role.
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Introduction
Despite significant advances in the management of cardiovas-
cular disease, it remains the predominant cause of morbidity
and mortality in Western countries [1]. The risk of developing
cardiovascular disease increases with age and is associated with
progressive impairment of cardiovascular repair mechanisms,
including the capacity of the heart to replace damaged cells [2].
In recent years, cell therapy has been studied intensively as
novel therapeutic option for cardiac diseases. After transplanta-
tion and engraftment of cells in the host myocardium, different
mechanisms are thought to be responsible for the improvement in
cardiac function, including angiogenesis and cardiomyogenesis
[3]. Mesenchymal stem cells (MSCs) are one of the cell types
studied in clinical trials for treatment of ischemic heart disease.
However, MSCs themselves are prone to the effects of aging and
disease and if autologous MSCs are used, may suffer from
decreased ability to proliferate, differentiate, home, engraft and
exert immunosuppressive effects [4,5]. Moreover, the develop-
mental stage of tissues and different states of disease alter the
microenvironmental regulation of stem cell behaviour [6].
Whether the developmental stage of MSC donor tissue also
affects the cardiac differentiation potential of MSCs is not
completely understood. While the role of MSCs in cardiac
development is largely unknown, several studies indicate that
MSCs derived from young cell sources, like umbilical cord blood,
appear to retain their primitive characteristics [7,8]. Also, some of
these MSCs seem to possess cardiovascular differentiation
potential in vitro and in vivo [9,10]. More recently, cells with
MSC-like characteristics have been derived from human
embryonic stem cells (ESCs) [11–15]. These cells resemble
hMSCs derived from various tissue sources with respect to
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entiation potential toward osteogenic, adipogenic and chrondro-
genic lineages [12,14]. More important, they lack expression of
pluripotency-associated markers, and after transplantation, no
teratoma formation has been reported [12,16]. MSCs derived
from human ESCs may therefore be mesoderm progenitors like
primitive MSCs and may constitute the most primitive committed
mesodermal cell type.
In this study, it was investigated whether the developmental
stage of the tissue, from which hMSCs were derived, had an effect
on the cardiac differentiation potential of these cells. To this end,
the ability of hMSCs derived from ESCs, fetal (amniotic mem-
brane, umbilical cord and bone marrow) and adult (adipose
tissue and bone marrow) tissue sources to differentiate towards
cardiomyocytes, smooth muscle cells and endothelial cells was
studied.
Materials and Methods
Isolation and culture of neonatal rat cardiomyocytes and
fibroblasts
All animal experiments were approved by the Animal
Experiments Committee of the Leiden University Medical Center
(LUMC) and conform to the Guide for the Care and Use of
Laboratory Animals, as stated by the US National Institutes of
Health (permit numbers: 09012 and 10236). Neonatal rat
ventricular cardiomyocytes (nrCMCs) and fibroblasts (nrCFBs)
were isolated and cultured as described previously [10].
Isolation, culture and characterization of hMSCs
All human-derived tissues were collected based on individual
written (parental) informed consent, after approval by the Medical
Ethics committee of the LUMC, where all investigations were
performed. The investigation conforms with the principles
outlined in the Declaration of Helsinki. Human mesenchymal
stem cells (hMSCs) were derived from embryonic stem cells
(hESC-MSCs), fetal amniotic membrane (amniotic), umbilical
cord (UC), bone marrow (BM), adult BM and adipose tissue
(adipose). Furthermore, fetal human skin fibroblasts (hSFBs) were
also isolated and used as control cells (see online supplement for
extensive description of cell isolation and culture procedures). All
hMSCs were characterized by flow cytometry, adipogenic and
osteogenic differentiation ability, immunocytological analyses,
growth kinetics and telomere length. After characterization, cells
were labeled with enhanced green fluorescent protein (eGFP) and
put in co-culture with nrCMCs or nrCFBs for 10 days to study
their cardiomyogenic differentiation potential. Differentiation was
assessed by human-specific immunocytological analyses, whole-cell
current-clamp recordings, human-specific quantitative reverse
transcription-polymerase chain reaction (qRT-PCR) analysis and
optical mapping of action potential propagation. In addition,
Western Blot analysis was used to study the expression of
connexin43 (Cx43) in relation to differentiation of hMSCs. All
experiments described below were conducted using hMSCs from
passage 3–6.
Flow cytometry
Analysis of surface marker expression was carried out by flow
cytometry using fluorescein isothiocyanate-, phycoerythrin- or
allophycocyanin-conjugated antibodies directed against human
CD105 (Ancell, Bayport, MN, USA), CD90, CD73, CD45,
CD34, CD31, CD24 and stage-specific embryonic antigen-4
(SSEA-4) (all from Becton Dickinson, Franklin Lakes, NJ, USA).
Adipogenic and osteogenic differentiation
Adipogenesis and osteogenesis of hMSCs were induced by
incubating hMSCs in appropriate differentiation media. Lipid
accumulation was assessed by Oil Red O (Sigma-Aldrich, St.
Louis, MO, USA), while calcium deposits were visualized by
staining the cells with 2% Alizarine Red S (Sigma-Aldrich).
Growth kinetics
Growth kinetics of the hMSCs was analyzed by calculating
population doublings (PDs). hMSCs were plated in triplicate and
trypsinized every 5 days and subjected to Trypan Blue staining to
determine the viable cell concentration using a hemocytometer.
Relative telomere length
Genomic DNA from experimental and reference samples was
obtained using DNAzol (Invitrogen, Breda, The Netherlands).
Relative telomere lengths were measured by SYBR Green-based
(Qiagen, Valencia, CA, USA) qRT-PCR amplification of telomere
repeats (T) and single-copy gene 36B4 (S) in a LightCycler 480
Real-Time PCR System (Roche, Foster City, CA, USA).
Immunocytochemical analyses
Co-cultures or monocultures were fixed in 4% paraformalde-
hyde, permeabilized with 0.1% Triton X-100, and stained with
primary antibodies. Primary antibodies specific for human lamin
A/C (Vector laboratories, Burlingame, CA, USA), SSEA-4, Oct3/
4 (both Santa Cruz Biotechnologies, Santa Cruz, CA, USA),
Nanog (R&D Systems, Minneapolis, MN, USA), CD90, CD73,
and CD105 were used to characterize hESC-MSCs. Co-cultures
were stained with a-actinin, Cx43 (both Sigma-Aldrich) and
human lamin A/C. Primary antibodies were visualized with Alexa
fluor-conjugated antibodies (Invitrogen). Nuclei were stained using
Hoechst 33342 (Invitrogen). A fluorescence microscope equipped
with a digital camera (Nikon Eclipse, Nikon Europe, Badhoeve-
dorp, The Netherlands) and dedicated software (Image-Pro Plus,
Version 4.1.0.0, Media Cybernetics, Silver Spring, MD, USA)
were used to analyze data. All cultures were treated equally using
the same antibody dilutions and exposure times.
Electrophysiological measurements in pharmacologically
uncoupled hMSCs in co-culture with nrCMCs
In order to study functional cardiomyogenic differentiation in
hMSCs, either eGFP-labeled fetal or adult hMSCs were put in co-
culture with nrCMCs and studied as described previously [10]. In
brief, at day 10 of co-culture, 180 mmol/L of 2-aminoethoxydi-
phenyl borate (2-APB) (Tocris, Ballwin, MO, USA) was added to
the extracellular solution, resulting in gap junction uncoupling
[17,18], which allowed for single-cell studies within the co-culture.
Next, whole-cell current-clamp recordings were performed in
eGFP-labeled hMSCs.
Human-specific quantitative reverse transcription PCR
Total cellular RNA was extracted from monocultures of hMSCs
and from co-cultures consisting of hMSCs and nrCMCs using the
RNeasy Mini kit (Qiagen). Oligo (dT)-primed reverse transcription
was performed on 2 mg of total cellular RNA and the resultant
cDNA was used for PCR amplification using SYBR Green. To
detect changes in cardiac and pluripotency gene expression levels,
only human-specific primers were used. The expression of the
genes of interest was normalized to that of the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Specific primer
information and annealing temperatures are provided in the
online supplement. Data were analyzed using the DCt method.
hMSCs and Cardiac Differentiation
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co-cultures of nrCMCs and different types of hMSCs
Action potential conduction velocity (CV) was investigated on a
whole-culture scale in wells of a 24-well plate by optically mapping
using the voltage-sensitive dye di-4-ANEPPS (Invitrogen). The
measurements were performed 10 days after seeding of either
8610
5 nrCMCs (nrCMC monoculture) or 8610
5 nrCMCs plus
8610
4 nrCFBs or 8610
4 hMSCs (nrCMC/nrCFB or nrCMC/
hMCS co-cultures) per well. The co-cultures were mapped using
the Ultima-L optical mapping setup (SciMedia, Costa Mesa, CA,
USA). Optical signal recordings were analyzed using Brain Vision
Analyze 0909 (Brainvision Inc, Tokyo, Japan). The CV of all (co-
)cultures was determined in a blinded manner.
Assessment of angiogenesis
All types of hMSCs were were plated on Matrigel (Becton
Dickinson) and cultured in Endothelial Growth Medium-2
(Cambrex IEP, Wiesbaden, Germany) containing 100 ng/mL
recombinant human VEGF-A165 (R&D Systems) up to 24 h to
determine their ability to form capillary-like structures. Following
culture under angiogenic conditions, cells were fixed and stained
with antibodies specific for smooth muscle myosin heavy chain
(smMHC; Sigma-Aldrich) and platelet/endothelial cell adhesion
molecule-1 (PECAM-1; Santa Cruz).
Western Blot analysis
Homogenates were made from at least 5 different isolations
of hMSCs per source. Equal amounts of protein were size-
fractionated in a 12% NuPage Tris-Acetate gel (Invitrogen) and
transferred to a Hybond-P PVDF membrane (GE Healthcare,
Waukesha, WI, USA). This membrane was incubated for 1 h with
an antibody against Cx43 followed by incubation with horse
radish peroxidase conjugated goat anti-rabbit secondary antibody
(Santa Cruz). To check for equal protein loading, the housekeep-
ing protein GAPDH (Chemicon International, Temecula, CA,
USA) was used.
Statistics
Experimental results were expressed as mean6standard devi-
ation (SD) for a given number (n) of observations. Data was
analyzed by Student’s t-test for direct comparisons. Analysis of
variance followed by the appropriate post-hoc analysis was per-
formed for multiple comparisons. Statistical analysis was per-
formed using SPSS 16.0 for Windows (SPSS Inc, Chicago, IL,
USA). Differences were considered statistically significant at
P,0.05.
A detailed description of the materials and methods can be
found in the Supplemental Materials and Methods S1.
Results
Isolation and characterization of hMSCs
All types of hMSCs displayed a spindle-shaped morphology
(Figure S1 A1–F1). To evaluate MSC properties, their surface
phenotype and adipogenic and osteogenic differentiation capacity
were studied. All types of hMSCs were negative for CD31
(endothelial cell marker), CD34, CD45 (hematopoietic cell
markers), and SSEA-4 (embryonic stem cell marker), whereas
they were positive for CD90, CD73 and CD105 (mesenchymal
cell markers). Furthermore, hESC-MSCs were negative for CD24,
indicating absence of hESCs in our cultures (Table S1). In vitro
differentiation assays confirmed that all types of hMSCs were able
to differentiate into adipocytes and osteoblasts thus confirming
their multipotent differentiation potential (Figure S1 A2–F2 and
A3–F3, respectively).
Growth kinetics
Comparison of the growth kinetics of hESC-MSCs with those of
fetal or adult hMSCs showed that hESC-MSCs had a significantly
larger replication capacity during 20 days in culture (35.1 PDs)
than any of the fetal hMSCs types (22.3–31.6 PDs) and both types
of adult MSCs (6.4–12.8 PDs) (P,0.001). Fetal hMSCs also
proliferated more rapidly and grew to higher densities than both
types of adult hMSCs (P,0.001) (Figure S1 G).
Telomere length
Replicative stability of hMSCs was determined by estimating
their relative telomere lengths (i.e. telomere repeat copy number
to single gene copy number [T/S] ratio). Relative telomere length
was significantly longer in hESC-MSCs (4.8760.7) and in fetal
hMSCs (2.4860.4) than in adult hMSCs (0.8960.2) (P,0.05;
n=10 samples from different isolations for each hMSC group).
Relative telomere length was also significantly longer in hESC-
MSCs than in fetal hMSCs (P,0.05; n=10 samples from different
isolations for each hMSC group) (Figure S1 H).
Immunocytological characterization of hESC-MSCs
All fibroblast-like cells derived from the hESC colonies
(Figure 1A1–A3) were recognized by a monoclonal antibody
specific for human lamin A/C confirming the human origin of
these cells (Figure 1B2). Murine MSCs (mMSCs), which served as
a negative control, were negative for this marker (Figure 1B1). In
addition, hESC-MSCs were negative for the undifferentiated
hESC marker SSEA-4 and the pluripotency markers Oct-4 and
Nanog (Figure 1C2–E2) in contrast to the hESC colonies from
which the fibroblast-like cells were derived (Figure 1C1–E1).
However, hESC-MSCs were positive for the mesenchymal cell
markers CD90, CD73 and CD105 (Figure S2 A1–A3).
Assessment of cardiomyogenic differentiation
Human-specific immunocytological evaluation. At day
10 of co-culture with nrCMCs, 7.1760.4% eGFP-labeled hESC-
MSCs (n=1,500 cells analyzed from 5 different isolations)
were positive for the sarcomeric protein a-actinin (Figure 2A1
and 2E), which was a significantly higher fraction than the
percentage of fetal hMSCs staining for a-actinin (fetal amniotic
MSCs 2.1560.2%, fetal BM MSCs 1.860.3% and fetal UC
MSCs 2.5660.7%, n=1,200 cells analyzed from 4 different
isolations per type of fetal hMSC) (P,0.001) (Figure 2B and
2E). Furthermore, in some of the hESC-MSCs (30.8%), fetal
amniotic MSCs (25.8%) and fetal BM MSCs (5.89%) a-actinin
was distributed in a cross-striated pattern typical for CMCs.
After 10 days of co-culture with nrCMCs, adult BM and
adipose MSCs did not stain for a-actinin (n=1,200 cells
analyzed from 4 different isolations per type of adult hMSC)
(Figure 2C and 2E). eGFP-labeled fetal hSFBs in co-culture
with nrCMCs were not positive for a-actinin (n=1,200 cells
analyzed from 4 different isolations) (Figure 2D and 2E) indicating
that not all fibroblastic human cell types acquire cardiomyocyte
properties in co-culture with nrCMCs. To exclude fusion of
nrCMCs with hMSCs or secondary transduction of nrCMCs
with eGFP, all co-cultures were also stained for human-specific
lamin A/C. None of the eGFP positive cells were negative for
human-specific lamin A/C or contained multiple nuclei (n$8,500
eGFP-positive cells analyzed) confirming the validity of the assay
system.
hMSCs and Cardiac Differentiation
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24164To assess the influence of the cellular microenvironment on
cardiomyogenic differentiation of hESC-MSCs and fetal hMSCs
the presence of a-actinin in these cells after 10 days of co-culture
with nrCFBs rather than nrCMCs was determined. Alpha-actinin
was not expressed by hESC-MSCs (Figure 3A1) or any of the fetal
hMSC types (Figure 3A2) after co-culture with nrCFBs (n=1,200
cells analyzed from 3 different isolation of each hMSC type)
(Figure 3B).
Intracellular electrophysiological measurements in
pharmacologically uncoupled hMSCs in co-culture with
nrCMCs. Patch-clamp recordings were obtained from eGFP-
labeled fetal and adult hMSCs at day 10 of co-culture with
nrCMCs after electrical isolation through incubation with the gap
junction uncoupler 2-APB. Action potentials could only be
measured in fetal hMSCs (n=5, amniotic), this in contrast to
adult hMSCs (n=8, adipose), which only showed steady
membrane potentials (Figure 2F). Selection of cells was based on
eGFP-labeling and the presence of 2–4 nrCMCs adjacent to the
cells of interest.
Human-specific qRT-PCR analysis to detect pluripotency
and cardiac differentiation. qRT-PCR showed that at the
mRNA level, hESC-MSCs expressed the following cardiac
markers: Nkx2.5, GATA-4, ANP, MLC2v and Cx43. These
mRNAs were upregulated after co-culture with nrCMCs
(P,0.001 for both ANP and MLC2v; P,0.01 for Nkx2.5;
P,0.05 for both GATA-4 and Cx43). However, Islet-1 and c-kit
mRNA levels were lower in co-cultured hESC-MSCs compared to
hESC-MSC monocultures (P,0.01 and P,0.05, respectively). No
significant difference in gene expression of VEGF was detected in
hESC-MSCs before or after co-incubation with nrCMCs
(Figure 4A). Fetal amniotic hMSCs showed an increase in
Nkx2.5 (P,0.05), ANP, Cx43 and VEGF (all P,0.01) gene
expression after co-culture with nrCMCs, while Islet-1 mRNA
levels were decreased under these circumstances (P,0.05). No
Figure 1. Characterization of hESC-MSCs. (A1) Bright field image of a hESC colony in which the cells at the periphery are differentiating toward
spindle-shaped fibroblast-like cells and (A2–A3) pure cultures of hESC-MSC. (B1–B2) Confirmation of the human origin of the hMSCs derived from
hESC colonies with the aid of a human-specific lamin A/C antibody. Incubation of murine MSCs (mMSCs; negative control cells) with this antibody (B1)
did not produce signal corroborating its species specificity. (C1–E2) Immunostaining of hESC colonies and hMSCs derived from these colonies for the
embryonic stem cell marker SSEA-4 and the pluripotency markers Oct-4 and Nanog. Nuclei were detected with Hoechst.
doi:10.1371/journal.pone.0024164.g001
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hMSCs before or after co-incubation with nrCMCs (Figure 4B). In
fetal UC hMSCs, mRNA levels of GATA-4, Cx43 (both P,0.05)
and VEGF (P,0.001) were significantly upregulated after their co-
culture with nrCMCs, while Islet-1 and c-kit gene expression were
downregulated (P,0.001 and P,0.01, respectively). No change in
the expression of ANP was detected in fetal UC hMSCs following
co-incubation with nrCMCs (Figure 4C). Fetal BM hMSCs
showed an increase in ANP (P,0.001), Cx43 and c-kit (both
P,0.05) gene expression co-incubation with nrCMCs, while no
difference in Islet-1 and VEGF mRNA levels were detected under
these circumstances (Figure 4D). At the mRNA level, ANP, Cx43,
VEGF and c-kit were detected in adult BM and adipose hMSCs.
However, after co-culture with nrCMCs, only the expression of
ANP (P,0.05) and VEGF (P,0.01) increased in both types of
adult hMSCs. In adult adipose hMSCs c-kit mRNA levels were
also upregulated in the presence of nrCMCs (P,0.05) (Figure 4E–
4F). Oct-4, Nanog, cTnI and b-MHC gene expression was not
detected in any of the hMSC types. qRT-PCR analysis of RNA
from appropriate human control samples confirmed the
functionality of all human-specific primer pairs. The same
primer pairs did not give rise to amplification products using
nrCMC RNA as starting material. Expression of the qRT-PCR
target genes in nrCMCs was confirmed using rat-specific primers.
Quantitative differences in gene expression between hMSCs
cultured alone or with nrCMCs are given in Table S2.
Optical mapping analysis to determine action potential
CV in co-cultures of nrCMCs with different types of
hMSCs. CV in nrCMC co-cultures with hESC-MSCs
(25.960.9 cm/s) was similar to the CV in nrCMC cultures
alone (24.861.2 cm/s) (Figure 5B1–B2 and 5C). However, it was
significantly higher than in co-cultures of nrCMCs with fetal
Figure 2. Immunocytological assessment of cardiomyogenic differentiation of different types of hMSCs after 10 days of co-culture
with nrCMCs. (A1–B3) A fraction of eGFP-labeled, human-specific lamin A/C positive hESC-MSCs and fetal amniotic, BM and UC hMSCs expressed a-
actinin (indicated as a-act), while (C1–C2) adult BM and adipose hMSCs did not. (D) eGFP-labeled human fetal skin fibroblasts (hSFBs; negative control
cells) in co-culture with nrCMCs did not stain positive for a-actinin. (E) Quantitative analysis of the cardiomyogenic differentiation of different types of
hMSCs. The graph is based on a minimum of 1,200 cells analyzed from 4 separate isolations per hMSC type.
#P,0.001 vs all fetal and adult hMSC
types;
*P,0.05 vs adult hMSCs; ND is not detected. (F) Intracellular electrophysiological measurements in fetal (amniotic) and adult (adipose) hMSCs
at day 10 of co-culture with nrCMCs and after pharmacological uncoupling of gap junctions. Intrinsic action potentials could be recorded from eGFP-
labeled fetal cells, while adult hMSCs showed only steady membrane potentials.
doi:10.1371/journal.pone.0024164.g002
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(18.261.1 cm/s) and nrCFBs (17.061.2 cm/s) (P,0.001; n$15
co-cultures with each cell type) (Figure 5B3–B5 and C). CV was
also higher in co-cultures of nrCMCs with fetal amniotic hMSCs
than in co-cultures with adult adipose hMSCs or with nrCFBs
(P,0.001) (Figure 5B3–B5 and C).
In vitro angiogenesis assays
hESC-MSCs and all types of fetal hMSCs were able to form
capillary-like structures on Matrigel (n$5 isolations of each hMSC
type incubated in triplicate) (Figure 6A1–D1). These networks
stained positively for the smooth muscle marker smMHC and the
endothelial cell marker PECAM-1 (Figure 6A2–D2). Formation of
cellular networks was established by hESC-MSCs 12 h after
incubation on Matrigel. For hMSCs derived from the fetal sources
it took 18 h to establish capillary-like networks. Adult BM and
adipose tissue hMSCs failed to form capillary-like structures (n$5
isolations of each hMSC type incubated in triplicate) (Figure 6E–
F). Formation of vessel-like networks was checked every hour for a
total period of 24 h.
Evaluation of Cx43 expression levels
To further analyze mechanisms underlying differences in
cardiomyogenic potential, Cx43 expression levels were evaluated.
Immunocytological analysis showed that Cx43 protein expression
was more abundant in hESC-MSCs and fetal amniotic MSCs than
in adult adipose MSCs and nrCFBs (n=5 isolations of each hMSC
type were assessed) (Figure 7A). These results were confirmed by
Western blot analysis (n=5 different isolations for each cell type)
(Figure 7C). Cx43 expression was also detected at the inter-
faces between nrCMCs and hESC-MSCs or fetal MSCs, while
under equivalent staining conditions it was not present at contact-
areas between nrCMCs and adult hMSCs or nrCFBs (Figure 7A).
Moreover, Cx43 did not line borders between nrCFBs and any
of the types of hMSCs (n$1,500 cells analyzed from 5 isolations
of each cell type under each condition) (Figure 7A). qRT-
PCR showed a significant increase in Cx43 expression following
the incubation of hESC-MSCs or fetal amniotic hMSCs with
nrCMCs (9.1460.9 (P,0.01) and 3.9460.5 fold (P,0.001),
respectively), while no (hESC-MSCs) or 19.460.1 fold less (fetal
amniotic hMSCs) Cx43 mRNA was detected in co-cultures with
nrCFBs (P,0.05) (Figure 7B1–B2). No significant difference in
Cx43 mRNA levels was detected between adult adipose tissue
hMSCs cultured alone or together with nrCMCs or nrCFBs
(Figure 7B3).
Discussion
Key findings of the present study are: 1) Differentiation
potential of hMSCs toward three cardiac cell lineages depends
on the developmental stage of donor tissue; 2) Cardiomyogenesis
of hMSCs is influenced by stimuli from the cellular microenvi-
ronment; and 3) The propensity of different types of hMSCs to
acquire properties of heart muscle cells correlates with Cx43
expression levels.
Development and Stemness
During embryonic development, stem cells contribute to organ
formation, while later in life these cells or their derivatives are
involved in repair and regeneration of organs [6]. However, with
increasing age, the potential of stem cells declines [19,20]. This
decrease in the regenerative ability is associated with cumulative
organ dysfunction, which may lead to increased morbidity and
mortality. Consistent with this developmental stage-dependent
decline in function of stem cells, this study showed that MSCs
derived from hESCs have significantly greater proliferative
capacity and longer telomeres than MSCs derived from human
fetal tissue, or adult hMSCs. The intrinsic age-associated decrease
in telomere length is one of the mechanisms that contributes to the
loss of stem cell properties with age [21]. The results of this first-
time direct comparison of the proliferative capacity of hESC-
MSCs, fetal hMSCs and adult hMSCs are in line with previous
studies [12,13,22–24]. All together, these findings show that MSCs
derived from human ESCs are more immature and display greater
stemness than those derived from fetal tissues.
MSCs and cardiac differentiation
In the present study, it was also shown that hMSCs derived
from either embryonic or fetal sources have the capacity to
undergo cardiac differentiation, while those derived from adult
sources do not. Our results revealed that developmental stage of
the donor tissue not only influences the ability of hMSCs to
differentiate into CMCs but also their capacity to undergo smooth
Figure 3. Study of cardiomyogenic differentiation in hESC-MSCs and fetal hMSCs after co-culture with nrCFBs for 10 days assessed
by immunocytological analysis. (A1–A2) No a-actinin expression, indicated as a-act, was detected in eGFP-labeled, human-specific lamin A/C
positive hESC-MSCs or fetal hMSCs after co-incubation with nrCFBs. Nuclei were detected with Hoechst. (B) Quantitative analysis of cardiomyogenic
differentiation of hESC-MSCs and all of the fetal hMSC types co-cultured with nrCFBs or nrCMCs. The graph is based on a minimum of 1,200 cells
analyzed from 3 separate isolations per hMSC type.
#P,0.001 vs hESC-MSCs and fetal hMSCs co-cultured with nrCFBs and fetal hMSCs in co-culture
with nrCMCs;
*P,0.01 vs fetal hESC-MSCs and fetal hMSCs co-cultured with nrCFBs; ND is not detected.
doi:10.1371/journal.pone.0024164.g003
hMSCs and Cardiac Differentiation
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value in extending the repertoire of cells considered suitable for
studies of cardiac repair. We showed that after co-culture with
nrCMCs the sarcomeric protein a-actinin is expressed by a
significantly higher percentage of hESC-MSCs than of fetal
hMSCs, while it was not expressed by adult hMSCs. Although the
cardiomyogenic potential of MSCs derived from neonatal sources
has been described before, a direct comparison of hMSCs derived
from embryonic, fetal and adult sources was not conducted [9,10].
Controversy still exists on whether MSCs actually differentiate
into CMCs or whether this apparent cardiomyogenesis is due to
fusion of MSCs with CMCs [25]. Therefore, in all our co-culture
experiments eGFP-transduced hMSCs were stained for human-
specific lamin A/C. Neither multinucleated eGFP positive cells
nor eGFP positive cells negative for human-specific lamin A/C
were detected. In addition, only human-specific primers were
used in the qRT-PCR experiments to exclude detection of rat
cardiac-specific genes expressed by nrCMCs. Accordingly, the
cardiomyogenic differentiation of hMSCs observed in our
experiments does not result from cell fusion. Importantly, the
records of intrinsic action potentials in eGFP positive cells at day
10 of co-culture provides direct evidence for functional cardio-
myogenic differentiation.
With respect to smooth muscle and endothelial differentiation,
only hESC-MSCs and fetal hMSCs were able to form capillary-
like structures on Matrigel. These networks stained positive for the
smooth muscle marker smMHC and the endothelial marker
PECAM-1. Previous studies showed that adult BM-derived MSCs
were able to form capillary-like structures after priming the cells in
endothelial differentiation medium. However, after priming, UC
hMSCs had higher endothelial potential than adult BM hMSCs
[26,27].
Concerning the underlying mechanisms why adult hMSCs do
not form CMCs, Cx43 expression may be of importance. In this
Figure 4. Analysis by qRT-PCR of expression of pluripotency and cardiac genes in hMSCs alone or after co-incubation with nrCMCs.
(A) hESC-MSCs expressed most cardiac-specific genes, which were significantly upregulated after co-incubation with nrCMCs. Expression of the
cardiac progenitor genes, Islet-1 and c-kit, was downregulated in the presence of nrCMCs. (B–D) The fetal hMSC types expressed a variety of cardiac-
specific genes, which were upregulated after co-culture with nrCMCs. Islet-1 and c-kit mRNA levels decreased in the presence of nrCMCs with the
exception of the upregulation of c-kit gene expression in fetal BM MSCs following their co-culture with nrCMCs. (E–F) ANP, Cx43, VEGF and c-kit gene
expression was detected in adult hMSCs before and after co-incubation with nrCMCs. (A–F) hMSCs did not express the pluripotency genes Oct-4 and
Nanog.
#P,0.05 vs specific hMSC monoculture;
*P,0.01 vs specific hMSC monoculture;
{P,0.001 vs specific hMSC monoculture.
doi:10.1371/journal.pone.0024164.g004
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contact between these two cell types, and allowing the possibility
for gap junction formation. Gap junctions, which in the ventricles
are mainly formed by Cx43, allow a low-resistant spread of
chemical and electrical signals between adjacent cells [28].
Interestingly, hMSCs derived from adult human sources express
very low levels of Cx43, both at mRNA and protein level, as
compared to hMSCs derived from embryonic and fetal sources. In
addition, hMSCs, which underwent functional cardiomyogenic
differentiation, were always adjacent to native CMCs, naturally
containing high levels of Cx43. As hMSCs are able to form
functional gap junctions with adjacent CMCs [29], electrical and
chemical interaction can occur between both cell types and this
was shown to play a role in cardiomyogenic differentiation [30].
Interestingly, co-culture of MSCs with cardiac fibroblasts,
expressing very low levels of Cx43, did not result in cardiomyo-
genic differentiation. In fact, using human-specific primers, Cx43
expression levels in hMSCs were shown to decrease significantly in
this microenvironment.
As Cx43 plays an essential role in myocardial electrical
conduction across the ventricular muscle, and cardiomyogenic
differentiation would make non-excitable MSCs become excitable,
we also studied the CV across co-cultures of hMSCs with
nrCMCs. It was shown that co-cultures with hESC-MSCs showed
a significantly higher CV than those with fetal hMSCs and adult
hMSCs, while the CV in co-cultures with fetal hMSCs was also
significantly higher than that in those with adult hMSCs. Of note,
embryonic MSCs did not only show high expression of Cx43, but
had the greatest cardiomyogenic differentiation potential. The
type of MSC that contributes to the highest CV may be preferable
to accomplish functional integration with host myocardium after
transplantation.
MSC transplantation for cardiac diseases
Besides providing new insights into the factors that stimulate
cardiac differentiation, the findings of this study may also have
implications for the use of MSCs in patients. Currently, in
myocardial cell therapy studies mainly autologous cells from aged
patients suffering from chronic diseases are used. Based on our
results, it may be expected that the therapeutic effects of MSC
transplantation, to improve cardiac function, are affected by
intrinsic properties of the transplanted cells. Furthermore, the
Figure 5. Assessment of CV by optical mapping in co-cultures of nrCMCs and different types of hMSCs. (A) The presence of hMSCs and
nrCFBs after optical mapping was confirmed by immunostaining for human-specific lamin A/C and collagen type I, respectively. Nuclei were detected
with Hoechst. (B) Activation maps of the different (co-)cultures reveal significantly higher CVs in nrCMCs monocultures and in hESC-MSCs/nrCMC and
fetal amniotic hMSCs/nrCMC co-cultures than in co-cultures of nrCMCs with adult adipose hMSCs or with nrCFBs. CVs were also significantly higher in
nrCMC monocultures and in hESC-MSCs/nrCMC co-cultures than in co-cultures between nrCMCs and fetal amniotic hMSCs. Spacing of isochronal
lines in activation maps is 4 ms, and colors indicate temporal sequence of activation, starting from the red area. (C) Bar graph of the CVs in nrCMC
monocultures and in co-cultures (+) between nrCMCs and nrCFBs or different types of hMSCs as indicated.
#P,0.001 vs fetal amniotic hMSCs, adult
adipose hMSCs and nrCFBs co-incubated with nrCMCs;
*P,0.01 vs adult adipose hMSCs and nrCFBs co-incubated with nrCMCs.
doi:10.1371/journal.pone.0024164.g005
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to be largely mediated by paracrine factors promoting neo-
angiogenesis and CMC survival with little evidence of the
differentiation of transplanted cells into CMCs [3]. As these
effects will be of limited help in case of extensive loss of myocardial
tissue there is still a great demand for stem cells that can
differentiate in vivo into new CMCs. In this study, we have shown
that hMSCs of prenatal origin can differentiate into functional
CMCs and that this process is dependent on instructive cues
provided by neighboring CMCs. Therefore selection of MSCs
from donor sources, such as the umbilical cord or amniotic
membrane/fluid, may be an attractive source of immature or
young cells for autologous cell transplantation. Even allogeneic
transplantation may be considered as MSCs are reported to have
immunomodulatory properties [31–33]. However, many aspects
related to transplantation of cardiomyogenic stem cells need to be
studied in more detail before optimal therapeutic efficacy and
minimal hazardous potential can be achieved.
Conclusions
Human MSCs of embryonic stem cell or fetal but not adult
origin can differentiate into three cardiac lineages: cardiomyo-
cytes, endothelial cells and smooth muscle cells. The ability to
undergo functional cardiomyogenic differentiation is amongst
others determined by the microenvironment of the cells, in
particular their communication with adjacent cell types. The gap
Figure 6. Angiogenic differentiation capacity of different types of hMSCs assessed by formation of capillary-like structures and
expression of angiogenic markers following their culture on Matrigel. (A1–D1) Bright field images show that hESC-MSCs and fetal hMSCs
were able to form stable cellular networks on a basement membrane matrix, while (E1–F1) adult hMSCs could not. (A2–D2) hESC-MSCs and all fetal
hMSC types stained positive for the endothelial cell protein, PECAM-1, and the smooth muscle cell protein, smMHC, while (E2–F2) the adult hMSCs
were negative for these markers. Nuclei were stained with Hoechst.
doi:10.1371/journal.pone.0024164.g006
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differentiation process.
Study limitations
It would have been more clinically relevant to co-culture the
different hMSC subtypes with adult human hCMCs, but obtaining
these cells in the numbers needed to conduct these experiments
seems not feasible. Furthermore, adult hCMCs cannot be cultured
long enough to perform some of the key experiments described in
this paper.
Supporting Information
Methods S1 A detailed description of the materials and methods
can be found in this supporting information file.
(DOC)
Figure S1 Cellular characteristics of hMSCs. (A1–F1) Bright
field images of cultured hMSCs displaying a spindle-shaped
morphology. (A2–F2) Presence of oil red O-stained fat vacuoles
after adipogenic differentiation. (A3–F3) Calcium depositions after
osteogenic differentiation was visualized by alizarine red S
staining. (A) hESC-MSC; (B) fetal amniotic hMSC; (C) fetal UC
hMSC; (D) fetal BM hMSC; (E) adult BM hMSC; (F) adult
adipose hMSC. (G) Growth kinetics of the different types of
hMSCs estimated by cumulative population doublings over 20
days (
*P,0.001 vs fetal hMSCs and adult hMSCs,
#P,0.001 vs
adult hMSCs). (H) Mean relative telomere lengths of hESC-MSCs,
all fetal hMSC types and both adult hMSC types (
*P,0.05 vs fetal
hMSCs and adult hMSCs,
#P,0.05 vs adult hMSCs).
(TIF)
Figure S2 Immunocytological characterization of hESC-MSCs
for MSC surface markers. Immunostaining of hESC-MSCs for
CD90, CD105 and CD73 (A1–A3) showed that these cells were
positive for these established MSC surface markers.
(TIF)
Table S1 Analysis of surface marker expression. All hMSC types
were positive for the established MSC surface markers CD105,
CD90 and CD73. They were negative for the hematopoietic,
endothelial and embryonic stem cell markers CD45 and CD34,
CD31 and SSEA-4, respectively. The hESC-MSCs were also
negative for CD24, a protein present on the surface of hESCs.
Mean percentages 6 standard deviations are given; n=6 for each
group. NT is not tested.
(DOC)
Table S2 qRT-PCR analysis to detect mRNAs associated with
cardiac differentiation. Indicated is the fold change in the
expression of cardiac genes in hMSCs cultured alone or together
Figure 7. Analysis by immunofluorescence microscopy, qRT-PCR and Western blotting of Cx43 expression in hMSC monocultures
and in co-cultures of nrCMCs or nrCFBs with different types of hMSCs. (A1–A2) Immunocytological analysis shows high Cx43 levels in
monocultures of hESC-MSCs and fetal amniotic hMSCs. Cx43 was also detected at the interfaces of these young hMSCs with nrCMCs but not with
nrCFBs. nrCMCs were visualized by staining with a-actinin (indicated as a-act), while an antibody against human-specific lamin A/C was used to
detect hMSCs. Nuclei were detected with Hoechst. (A3–A4) Adult adipose hMSCs contain very low amounts of Cx43 in both monocultures and co-
cultures with nrCMCs or nrCFBs. Also in nrCFB monocultures and nrCFB/nrCMC co-cultures Cx43 is barely detectable. (B1–B3) Bar graphs of the
assessment by qRT-PCR of Cx43 mRNA levels in hESC-MSC, fetal amniotic hMSC and adult adipose hMSC monocultures and co-cultures (+) of these
cells with either nrCMCs or nrCFBs as indicated. (C) Picture of representative part of a Western blot showing that hESC-MSCs and fetal amniotic hMSCs
contain large amounts of Cx43 in contrast to adult adipose hMSCs and nrCFBs. The housekeeping protein glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used to check for equal protein loading.
#P,0.05 vs hMSCs in co-culture with nrCFBs;
*P,0.01 vs hMSC monocultures
and hMSCs in co-culture with nrCFBs.
doi:10.1371/journal.pone.0024164.g007
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#P,0.05 vs hMSC monoculture;
*P,0.01 vs
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